Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387498976> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4387498976 abstract "Cancer is the primary and one of the most prominent causes of the rising global mortality rate, accounting for nearly 10 million deaths annually. Specific methods have been devised to cure cancerous tumours. Effective therapeutic approaches must be developed, both at the cellular and genetic level. Immunotherapy offers promising results by providing sustained remission to patients with refractory malignancies. Genetically modified T‑lymphocytic cells have emerged as a novel therapeutic approach for the treatment of solid tumours, haematological malignancies, and relapsed/refractory B‑lymphocyte malignancies as a result of recent clinical trial findings; the treatment is referred to as chimeric antigen receptor T‑cell therapy (CAR T‑cell therapy). Leukapheresis is used to remove T‑lymphocytes from the leukocytes, and CARs are created through genetic engineering. Without the aid of a major histocompatibility complex, these genetically modified receptors lyse malignant tissues by interacting directly with the carcinogen. Additionally, the outcomes of preclinical and clinical studies reveal that CAR T‑cell therapy has proven to be a potential therapeutic contender against metastatic breast cancer (BCa), triple‑negative, and HER 2+ve BCa. Nevertheless, unique toxicities, including (cytokine release syndrome, on/off‑target tumour recognition, neurotoxicities, anaphylaxis, antigen escape in BCa, and the immunosuppressive tumour microenvironment in solid tumours, negatively impact the mechanism of action of these receptors. In this review, the potential of CAR T‑cell immunotherapy and its method of destroying tumour cells is explored using data from preclinical and clinical trials, as well as providing an update on the approaches used to reduce toxicities, which may improve or broaden the effectiveness of the therapies used in BCa." @default.
- W4387498976 created "2023-10-11" @default.
- W4387498976 creator A5006658273 @default.
- W4387498976 creator A5024830865 @default.
- W4387498976 creator A5029644059 @default.
- W4387498976 creator A5029848805 @default.
- W4387498976 creator A5035988554 @default.
- W4387498976 creator A5039304444 @default.
- W4387498976 creator A5044727227 @default.
- W4387498976 creator A5051938836 @default.
- W4387498976 creator A5093036437 @default.
- W4387498976 creator A5093036438 @default.
- W4387498976 date "2023-10-10" @default.
- W4387498976 modified "2023-10-14" @default.
- W4387498976 title "Journey of CAR T‑cells: Emphasising the concepts and advancements in breast cancer (Review)" @default.
- W4387498976 doi "https://doi.org/10.3892/ijo.2023.5578" @default.
- W4387498976 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37830150" @default.
- W4387498976 hasPublicationYear "2023" @default.
- W4387498976 type Work @default.
- W4387498976 citedByCount "0" @default.
- W4387498976 crossrefType "journal-article" @default.
- W4387498976 hasAuthorship W4387498976A5006658273 @default.
- W4387498976 hasAuthorship W4387498976A5024830865 @default.
- W4387498976 hasAuthorship W4387498976A5029644059 @default.
- W4387498976 hasAuthorship W4387498976A5029848805 @default.
- W4387498976 hasAuthorship W4387498976A5035988554 @default.
- W4387498976 hasAuthorship W4387498976A5039304444 @default.
- W4387498976 hasAuthorship W4387498976A5044727227 @default.
- W4387498976 hasAuthorship W4387498976A5051938836 @default.
- W4387498976 hasAuthorship W4387498976A5093036437 @default.
- W4387498976 hasAuthorship W4387498976A5093036438 @default.
- W4387498976 hasBestOaLocation W43874989761 @default.
- W4387498976 hasConcept C121608353 @default.
- W4387498976 hasConcept C126322002 @default.
- W4387498976 hasConcept C143998085 @default.
- W4387498976 hasConcept C203014093 @default.
- W4387498976 hasConcept C2777701055 @default.
- W4387498976 hasConcept C2780850621 @default.
- W4387498976 hasConcept C3875195 @default.
- W4387498976 hasConcept C502942594 @default.
- W4387498976 hasConcept C530470458 @default.
- W4387498976 hasConcept C71924100 @default.
- W4387498976 hasConcept C86803240 @default.
- W4387498976 hasConceptScore W4387498976C121608353 @default.
- W4387498976 hasConceptScore W4387498976C126322002 @default.
- W4387498976 hasConceptScore W4387498976C143998085 @default.
- W4387498976 hasConceptScore W4387498976C203014093 @default.
- W4387498976 hasConceptScore W4387498976C2777701055 @default.
- W4387498976 hasConceptScore W4387498976C2780850621 @default.
- W4387498976 hasConceptScore W4387498976C3875195 @default.
- W4387498976 hasConceptScore W4387498976C502942594 @default.
- W4387498976 hasConceptScore W4387498976C530470458 @default.
- W4387498976 hasConceptScore W4387498976C71924100 @default.
- W4387498976 hasConceptScore W4387498976C86803240 @default.
- W4387498976 hasIssue "6" @default.
- W4387498976 hasLocation W43874989761 @default.
- W4387498976 hasLocation W43874989762 @default.
- W4387498976 hasOpenAccess W4387498976 @default.
- W4387498976 hasPrimaryLocation W43874989761 @default.
- W4387498976 hasRelatedWork W2251648452 @default.
- W4387498976 hasRelatedWork W2916176185 @default.
- W4387498976 hasRelatedWork W2917403768 @default.
- W4387498976 hasRelatedWork W2936186479 @default.
- W4387498976 hasRelatedWork W2952260713 @default.
- W4387498976 hasRelatedWork W2969241243 @default.
- W4387498976 hasRelatedWork W3028773865 @default.
- W4387498976 hasRelatedWork W3142239825 @default.
- W4387498976 hasRelatedWork W4220818326 @default.
- W4387498976 hasRelatedWork W4381594543 @default.
- W4387498976 hasVolume "63" @default.
- W4387498976 isParatext "false" @default.
- W4387498976 isRetracted "false" @default.
- W4387498976 workType "article" @default.